v3.26.1
Earnings Per Share (Tables)
 6 Months Ended
Jun. 27, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following table sets forth the computation of basic and diluted income per share of Class A common stock for the periods presented (amounts in thousands, except share and per share data):
Three Months EndedSix Months Ended
June 27, 2026June 28, 2025June 27, 2026June 28, 2025
Numerator
Net income$36,205 $9,272 $40,151 $5,950 
Less: Net income attributable to
    noncontrolling interest		(2,764)(1,813)(3,597)(1,128)
Net income attributable to Bioventus Inc.
    Class A common shareholders		$33,441 $7,459 $36,554 $4,822 
Denominator
Basic weighted-average shares of Class A
    common stock outstanding		67,869,148 66,500,433 67,589,178 66,258,679 
Dilutive effects of:
Stock options1,276,983 826,918 1,188,120 1,090,214 
Restricted stock units(a)
1,692,355 1,209,408 1,652,527 1,416,698 
Diluted weighted-average shares of Class A
    common stock outstanding		70,838,48668,536,75970,429,82568,765,591
Net income per share of Class A
    common stock—basic		$0.49 $0.11 $0.54 $0.07 
Net income per share of Class A
    common stock—diluted		$0.47 $0.11 $0.52 $0.07 
(a)Includes the dilutive effect of both restricted stock units and performance restricted stock units.
Schedule of Antidilutive Securities
The following number of weighted-average potentially dilutive shares were excluded from the calculation of diluted net income per share because the effect of including such potentially dilutive shares would have been antidilutive upon conversion:
Three Months EndedSix Months Ended
June 27, 2026June 28, 2025June 27, 2026June 28, 2025
LLC Interests held by Continuing LLC Owner(a)
15,786,737 15,786,737 15,786,737 15,786,737 
Stock options(b)
3,035,878 2,448,343 2,669,542 2,140,912 
Restricted stock units(c)
386,000 1,178,440 388,403 617,987 
Total19,208,615 19,413,520 18,844,682 18,545,636 
(a)Shares of Class A common stock reserved for future issuance upon redemption or exchange of LLC Interests by the Continuing LLC Owner. LLC Interests are neither dilutive nor antidilutive for the periods presented as the assumed redemption for shares of Class A common stock would cause a proportionate increase to net income attributable to Class A common shareholders—diluted.
(b)Options with exercise prices greater than the average market price of our Class A common stock are excluded from the computation of diluted net income per share because they are out-of-the-money.
(c)A portion of the restricted stock units and performance restricted stock units are considered antidilutive under the treasury stock method as the number of shares that could be purchased with the assumed proceeds of the restricted stock units exceed the total amount of the underlying shares outstanding.